Org 25935 Versus Placebo as Augmentation to Cognitive-behavioral Therapy to Treat Panic Disorder (P05705)
Status:
Terminated
Trial end date:
2010-04-23
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of Org 25935 vs. placebo given in
combination with cognitive-behavioral therapy (CBT) to reduce the symptoms of panic disorder.
It is hypothesized that treatment with Org 25935 at a dose of 4 mg or 12 mg will differ
significantly from placebo with respect to the Panic Disorder Severity Scale (PDSS) total
score over 3 weeks of therapy.